Innovations in Recombinant Antihemophilic Factor Therapy The advent of recombinant antihemophilic factor therapy represents a transformative milestone in the treatment of hemophilia. Hemophilia, a genetic disorder characterized by a deficiency in clotting factors, has historically been managed through blood transfusions and plasma-derived products. However, advancements in biochemistry have paved the way for recombinant technologies that […]
Recent Comments